MacroGenics to Participate in Upcoming Investor Conference

Rhea-AI Summary

MacroGenics, Inc. (MGNX) announced their participation in the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference in New York. The company's President and CEO, Scott Koenig, M.D., Ph.D., will take part in a fireside chat on February 7, 2024, at 2:00 pm ET. The management will also engage in one-on-one meetings. The webcast of the presentation can be accessed on the company's Investor Relations website, with an archived replay available for 30 days.

ROCKVILLE, MD, Feb. 02, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following upcoming investor conference:

• Guggenheim Healthcare Talks | 6^th Annual Biotechnology Conference (New York).  MacroGenics’ President and CEO, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Wednesday, February 7, 2024, at 2:00 pm ET. MacroGenics’ management will also participate in one-on-one meetings.

A webcast of the above presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm.  The Company will maintain an archived replay of this webcast on its website for 30 days.   

About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

###

FAQ

When is MacroGenics participating in the Guggenheim Healthcare Talks?

MacroGenics is participating in the Guggenheim Healthcare Talks on February 7, 2024.

Who will be taking part in the fireside chat at the conference?

The President and CEO of MacroGenics, Scott Koenig, M.D., Ph.D., will participate in the fireside chat.

Where can the webcast of the presentation be accessed?

The webcast can be accessed on the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm.

How long will the archived replay of the webcast be available?

The archived replay will be available on the company's website for 30 days.